Patents by Inventor Sesha Neervannan

Sesha Neervannan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220370346
    Abstract: Embodiments disclosed herein are directed to fixed compositions comprising brimonidine and timolol for lowering intraocular pressure and treating glaucoma.
    Type: Application
    Filed: December 16, 2021
    Publication date: November 24, 2022
    Inventors: Jim Jiao, Chin-Ming Chang, Anuradha V. Gore, Richard S. Graham, R. Scott Jordan, Sesha Neervannan, Chetan P. Pujara, Jie Shen, Kevin S. Warner
  • Patent number: 10780048
    Abstract: The present disclosure relates to suspension formulations and systems for the treatment of ocular conditions. The suspension formulations can include cyclosporin A and in some embodiments, Form 1 or Form 2 cyclosporin A. A delivery system can be provided that includes two parts, a first part containing particles of cyclosporin and a second part containing other components that can be combined with the first part to make a suspension formulation. The suspension can be injected into the subconjunctival or other periocular space to treat ocular conditions, such as dry eye disease.
    Type: Grant
    Filed: July 20, 2015
    Date of Patent: September 22, 2020
    Assignee: ALLERGAN, INC.
    Inventors: Anuradha V. Gore, Hao Hou, Chetan P. Pujara, Sesha Neervannan, Ke Wu
  • Publication number: 20190290722
    Abstract: Ophthalmic products and related methods are described herein. These methods include a stabilizing composition comprising a therapeutically active agent which is separated from a liquid vehicle composition by a barrier. The barrier may be removed to allow the two compositions to mix to provide an ophthalmically acceptable liquid comprising the therapeutically active agent.
    Type: Application
    Filed: June 10, 2019
    Publication date: September 26, 2019
    Inventors: Anuradha V. Gore, Sai M. Shankar, Sukhon Likitlersuang, Chetan P. Pujara, Sesha Neervannan
  • Patent number: 10314887
    Abstract: Ophthalmic products and related methods are described herein. These methods include a stabilizing composition comprising a therapeutically active agent which is separated from a liquid vehicle composition by a barrier. The barrier may be removed to allow the two compositions to mix to provide an ophthalmically acceptable liquid comprising the therapeutically active agent.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: June 11, 2019
    Assignee: Allergan, Inc.
    Inventors: Anuradha V. Gore, Sai M. Shankar, Sukhon Likitlersuang, Chetan P. Pujara, Sesha Neervannan
  • Publication number: 20180078500
    Abstract: Embodiments disclosed herein are directed to fixed compositions comprising brimonidine and timolol for lowering intraocular pressure and treating glaucoma.
    Type: Application
    Filed: March 17, 2016
    Publication date: March 22, 2018
    Inventors: Jim Jiao, Chin-Ming Chang, Anuradha V. Gore, Richard S. Graham, R. Scott Jordan, Sesha Neervannan, Chetan P. Pujara, Jie Shen, Kevin S. Warner
  • Publication number: 20170209532
    Abstract: Ophthalmic products and related methods are described herein. These methods include a stabilizing composition comprising a therapeutically active agent which is separated from a liquid vehicle composition by a barrier. The barrier may be removed to allow the two compositions to mix to provide an ophthalmically acceptable liquid comprising the therapeutically active agent.
    Type: Application
    Filed: April 10, 2017
    Publication date: July 27, 2017
    Inventors: Anuradha V. Gore, Sai M. Shankar, Sukhon Likitlersuang, Chetan P. Pujara, Sesha Neervannan
  • Patent number: 9616017
    Abstract: Ophthalmic products and related methods are described herein. These methods include a stabilizing composition comprising a therapeutically active agent which is separated from a liquid vehicle composition by a barrier. The barrier may be removed to allow the two compositions to mix to provide an ophthalmically acceptable liquid comprising the therapeutically active agent.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: April 11, 2017
    Assignee: Allergan, Inc.
    Inventors: Anuradha V. Gore, Sai Shankar, Sukhon Likitlersuang, Chetan P. Pujara, Sesha Neervannan
  • Publication number: 20160235666
    Abstract: Ophthalmic products and related methods are described herein. These methods include a stabilizing composition comprising a therapeutically active agent which is separated from a liquid vehicle composition by a barrier. The barrier may be removed to allow the two compositions to mix to provide an ophthalmically acceptable liquid comprising the therapeutically active agent.
    Type: Application
    Filed: April 22, 2016
    Publication date: August 18, 2016
    Inventors: Anuradha V. Gore, Sai M. Shankar, Sukhon Likitlersuang, Chetan P. Pujara, Sesha Neervannan
  • Publication number: 20160015632
    Abstract: The present disclosure relates to suspension formulations and systems for the treatment of ocular conditions. The suspension formulations can include cyclosporin A and in some embodiments, Form 1 or Form 2 cyclosporin A. A delivery system can be provided that includes two parts, a first part containing particles of cyclosporin and a second part containing other components that can be combined with the first part to make a suspension formulation. The suspension can be injected into the subconjunctival or other periocular space to treat ocular conditions, such as dry eye disease.
    Type: Application
    Filed: July 20, 2015
    Publication date: January 21, 2016
    Inventors: Anuradha V. Gore, Hoa Hou, Chetan P. Pujara, Sesha Neervannan, Ke Wu
  • Publication number: 20140249153
    Abstract: The present invention is directed to compositions comprising combinations of brimonidine and bimatoprost useful for lowering intraocular pressure in a patient and for the treatment of glaucoma.
    Type: Application
    Filed: July 20, 2012
    Publication date: September 4, 2014
    Applicant: Allergan, Inc.
    Inventors: Richard S. Graham, Chetan P. Pujara, Sesha Neervannan, Anuradha V. Gore, Kevin S. Warner
  • Publication number: 20130029919
    Abstract: Ophthalmic products and related methods are described herein. These methods include a stabilizing composition comprising a therapeutically active agent which is separated from a liquid vehicle composition by a barrier. The barrier may be removed to allow the two compositions to mix to provide an ophthalmically acceptable liquid comprising the therapeutically active agent.
    Type: Application
    Filed: July 25, 2012
    Publication date: January 31, 2013
    Applicant: ALLERGAN, INC.
    Inventors: Anuradha V. GORE, Sai M. SHANKAR, Sukhon LIKITLERSUANG, Chetan P. PUJARA, Sesha NEERVANNAN
  • Publication number: 20130023536
    Abstract: The present invention is directed to compositions comprising combinations of brimonidine and bimatoprost useful for lowering intraocular pressure in a patient and for the treatment of glaucoma
    Type: Application
    Filed: July 20, 2012
    Publication date: January 24, 2013
    Inventors: Richard S. Graham, Chetan P. Pujara, Sesha Neervannan, Anuradha V. Gore, Kevin S. Warner